FDA Perspective on Sofosbuvir Therapy for Patients With Chronic Hepatitis C Virus Genotype 1 Infection Who Did Not Respond to Treatment With Pegylated Interferon and Ribavirin期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

FDA Perspective on Sofosbuvir Therapy for Patients With Chronic Hepatitis C Virus Genotype 1 Infection Who Did Not Respond to Treatment With Pegylated Interferon and Ribavirin

Authors:	Poonam MishraJeffry Florian,Karen QiWen Zeng,Lisa K. NaegerEric Donaldson,Sarah ConnellyJules O&rsquo Rear,Dionne PriceJeffrey Murray,Debra Birnkrant

Affiliation:	US Food and Drug Administration, Silver Spring, Maryland

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！